POTE15 inhibitors are chemical compounds that specifically interact with and inhibit the function of the POTE15 protein, a member of the POTE gene family. The POTE family is characterized by proteins containing ankyrin repeats and coiled-coil domains, and is generally involved in cellular structural integrity, signaling pathways, and other essential cellular processes. POTE15, in particular, is a protein that shares many of these features and is expressed in various cell types. Inhibition of POTE15 involves compounds that bind to the protein, altering its structure or function in such a way that it can no longer perform its usual role. This inhibition is important for research efforts aimed at understanding how POTE15 contributes to cellular pathways and what effects its suppression may have on various biochemical processes within cells.
The development of POTE15 inhibitors requires a deep understanding of the molecular structure of the POTE15 protein, including its binding sites, the nature of its ankyrin repeats, and the coiled-coil domains that help it maintain its shape and interact with other cellular components. Researchers studying POTE15 inhibitors focus on the binding affinity and selectivity of these compounds, ensuring that they target POTE15 with minimal off-target effects. These inhibitors are useful for probing the biological function of POTE15, enabling scientists to investigate its role in key cellular processes. By selectively inhibiting POTE15, these chemical tools can also help identify other proteins or pathways that may interact with or rely on POTE15, thus expanding our understanding of cellular networks and regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes by affecting RNA polymerase II activity, potentially reducing the expression of POTE ankyrin domain family member B. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $255.00 | ||
Chromomycin A3 binds to GC-rich regions of DNA and inhibits RNA synthesis by preventing the binding of transcription factors, which can decrease gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that changes chromatin structure, which can upregulate or downregulate the expression of many genes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, leading to the buildup of misfolded proteins and potentially affecting gene expression through stress response pathways. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, disrupting DNA replication and transcription processes, which may lead to decreased gene expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin causes premature chain termination during translation, which could reduce overall protein synthesis and indirectly affect gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA and inhibits RNA polymerase, which can lead to a reduction in mRNA synthesis and gene expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin binds to the β subunit of RNA polymerase and inhibits RNA synthesis, potentially reducing the expression of various genes. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin intercalates into DNA, disrupting the function of topoisomerase II and affecting DNA replication and transcription. | ||||||
SN 38 | 86639-52-3 | sc-203697 sc-203697A sc-203697B | 10 mg 50 mg 500 mg | $117.00 $335.00 $883.00 | 19 | |
SN-38 is the active metabolite of irinotecan and inhibits DNA topoisomerase I, which is crucial for DNA replication and transcription. | ||||||